ArticleCancer medicine2020

First-line crizotinib versus platinum-pemetrexed chemotherapy in patients with advanced ROS1-rearranged non-small-cell lung cancer.

Lan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.